Valuation: Kenvue Inc.

Market Cap 36.83B 31.96B 29.92B 27.37B 51.68B 3,508B 52.35B 350B 137B 1,753B 138B 135B 5,834B P/E 2026 *
20.2x
P/E 2027 * 17.7x
Enterprise Value 43.38B 37.65B 35.25B 32.25B 60.88B 4,133B 61.67B 412B 162B 2,065B 163B 159B 6,872B EV / Sales 2026 *
2.77x
EV / Sales 2027 * 2.72x
Free-Float
98.9%
Yield 2026 *
4.47%
Yield 2027 * 4.5%
1 day-2.49%
1 week-0.67%
Current month-0.31%
1 month-1.94%
3 months+8.48%
6 months+5.79%
Current year+11.19%
1 week 18.68
Extreme 18.685
19.7
1 month 18.58
Extreme 18.58
20.05
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.96
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Fiscal year

Executive/Senior Manager

32,838 0.0017%
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.49%-0.67%-10.54%-18.49% 36.83B
+0.12%+2.09%-3.85%-5.35% 342B
-1.36%-2.91%-7.29%+2.33% 136B
-0.30%+1.53%+9.92%+21.95% 74.14B
+0.75%-0.33%-16.81%-18.48% 51.29B
-1.69%+0.72%-5.17%-49.91% 30.93B
-0.34%+1.41%-16.07%-31.45% 20.59B
-0.32%+1.51%+15.68%+10.51% 20.09B
+1.78%+12.03%+7.52%+29.46% 20.54B
+0.19%+0.77%-11.59%+4.65% 11.57B
Average -0.51%+0.75%-3.82%-5.48% 74.4B
Weighted average by Cap. -1.00%+0.00%-4.01%-3.81%

Financials

2026 *2027 *
Net sales 15.65B 13.58B 12.72B 11.63B 21.96B 1,491B 22.25B 149B 58.39B 745B 58.76B 57.49B 2,479B 16.01B 13.89B 13.01B 11.9B 22.47B 1,525B 22.76B 152B 59.73B 762B 60.11B 58.81B 2,536B
Net income 1.83B 1.59B 1.49B 1.36B 2.57B 174B 2.6B 17.39B 6.82B 87.06B 6.87B 6.72B 290B 2.09B 1.82B 1.7B 1.56B 2.94B 199B 2.98B 19.9B 7.81B 99.64B 7.86B 7.69B 332B
Net Debt 6.56B 5.69B 5.33B 4.87B 9.2B 625B 9.32B 62.33B 24.46B 312B 24.62B 24.08B 1,039B 6.8B 5.9B 5.52B 5.05B 9.54B 647B 9.66B 64.6B 25.35B 323B 25.51B 24.96B 1,076B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-06 US$19.18 -2.49% 25,328,494
26-08-05 US$19.67 +0.61% 32,808,027
26-08-04 US$19.55 +2.84% 23,595,514
26-08-03 US$19.01 -1.20% 35,167,488
26-07-31 US$19.24 -0.36% 22,744,382
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.18USD
Average target price
19.83USD
Spread / Average Target
+3.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock